{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:27:20Z","timestamp":1768285640083,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"DOI":"10.7759\/cureus.99999","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:33:41Z","timestamp":1766579621000},"source":"Crossref","is-referenced-by-count":1,"title":["Balancing Bleeding and Clot: Type 2 Heparin-Induced Thrombocytopenia With Extensive Thromboses in a Patient With Subdural Hematoma"],"prefix":"10.7759","author":[{"given":"George K","family":"Annan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enoch","family":"Enninful","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinenye","family":"Egwuonwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley E","family":"Atencah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick O","family":"Berchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th Ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Linkins LA","year":"2012","unstructured":"Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crowther M. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th Ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012, 141:e495S-530S. 10.1378\/chest.11-2303","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally GM","year":"2017","unstructured":"Arepally GM. Heparin-induced thrombocytopenia. Blood. 2017, 129:2864-72. 10.1182\/blood-2016-11-709873","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X19898253","article-title":"Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management","volume":"25","author":"Hogan M","year":"2020","unstructured":"Hogan M, Berger JS. Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management. Vasc Med. 2020, 25:160-73. 10.1177\/1358863X19898253","journal-title":"Vasc Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1411910","article-title":"Clinical practice. Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher A","year":"2015","unstructured":"Greinacher A. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2015, 373:252-61. 10.1056\/NEJMcp1411910","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098217","article-title":"Novel knowledge about molecular mechanisms of heparin-induced thrombocytopenia type II and treatment targets","volume":"24","author":"Mongirdien\u0117 A","year":"2023","unstructured":"Mongirdien\u0117 A, Liuiz\u0117 A, Ka\u0161auskas A. Novel knowledge about molecular mechanisms of heparin-induced thrombocytopenia type II and treatment targets. Int J Mol Sci. 2023, 24:8217. 10.3390\/ijms24098217","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1602664","article-title":"Heparin-induced thrombocytopenia in cardiac surgery patients","volume":"43","author":"Pishko AM","year":"2017","unstructured":"Pishko AM, Cuker A. Heparin-induced thrombocytopenia in cardiac surgery patients. Semin Thromb Hemost. 2017, 43:691-8. 10.1055\/s-0037-1602664","journal-title":"Semin Thromb Hemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2013.07.021","article-title":"Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: an analysis of the nationwide inpatient sample","volume":"28","author":"Seigerman M","year":"2014","unstructured":"Seigerman M, Cavallaro P, Itagaki S, Chung I, Chikwe J. Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: an analysis of the nationwide inpatient sample. J Cardiothorac Vasc Anesth. 2014, 28:98-102. 10.1053\/j.jvca.2013.07.021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4Ts) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo GK","year":"2006","unstructured":"Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4Ts) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006, 4:759-65. 10.1111\/j.1538-7836.2006.01787.x","journal-title":"J Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker A","year":"2018","unstructured":"Cuker A, Arepally GM, Chong BH, et al.. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018, 2:3360-92. 10.1182\/bloodadvances.2018024489","journal-title":"Blood Adv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-03-0240","article-title":"Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia","volume":"116","author":"Nagler M","year":"2016","unstructured":"Nagler M, Bakchoul T. Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost. 2016, 116:823-34. 10.1160\/TH16-03-0240","journal-title":"Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164686","article-title":"Management of heparin-induced thrombocytopenia: a contemporary review","volume":"13","author":"Ng JY","year":"2024","unstructured":"Ng JY, D'Souza M, Hutani F, Choi P. Management of heparin-induced thrombocytopenia: a contemporary review. J Clin Med. 2024, 13:4686. 10.3390\/jcm13164686","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12169","article-title":"Fondaparinux in heparin-induced thrombocytopenia: a decade's worth of clinical experience","volume":"3","author":"Schindewolf M","year":"2019","unstructured":"Schindewolf M. Fondaparinux in heparin-induced thrombocytopenia: a decade's worth of clinical experience. Res Pract Thromb Haemost. 2019, 3:9-11. 10.1002\/rth2.12169","journal-title":"Res Pract Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-017-1566-1","article-title":"High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation","volume":"45","author":"Castelli R","year":"2018","unstructured":"Castelli R, Gallipoli P, Schiavon R, Teatini T, Deliliers GL, Bergamaschini L. High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation. J Thromb Thrombolysis. 2018, 45:106-13. 10.1007\/s11239-017-1566-1","journal-title":"J Thromb Thrombolysis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24006","article-title":"The platelet serotonin-release assay","volume":"90","author":"Warkentin TE","year":"2015","unstructured":"Warkentin TE, Arnold DM, Nazi I, Kelton JG. The platelet serotonin-release assay. Am J Hematol. 2015, 90:564-72. 10.1002\/ajh.24006","journal-title":"Am J Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.01.001","article-title":"Platelet-activating antibodies are detectable at the earliest onset of heparin-induced thrombocytopenia, with implications for the operating characteristics of the serotonin-release assay","volume":"153","author":"Warkentin TE","year":"2018","unstructured":"Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I. Platelet-activating antibodies are detectable at the earliest onset of heparin-induced thrombocytopenia, with implications for the operating characteristics of the serotonin-release assay. Chest. 2018, 153:1396-404. 10.1016\/j.chest.2018.01.001","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13537","article-title":"Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia","volume":"47","author":"Cirbus K","year":"2022","unstructured":"Cirbus K, Simone P, Austin Szwak J. Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia. J Clin Pharm Ther. 2022, 47:112-8. 10.1111\/jcpt.13537","journal-title":"J Clin Pharm Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-022-02705-6","article-title":"Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia","volume":"54","author":"Albuloushi A","year":"2022","unstructured":"Albuloushi A, Rhoten M, Kelly J, Sylvester KW, Grandoni J, Connors JM. Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2022, 54:597-604. 10.1007\/s11239-022-02705-6","journal-title":"J Thromb Thrombolysis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437741-balancing-bleeding-and-clot-type-2-heparin-induced-thrombocytopenia-with-extensive-thromboses-in-a-patient-with-subdural-hematoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:33:42Z","timestamp":1766579622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437741-balancing-bleeding-and-clot-type-2-heparin-induced-thrombocytopenia-with-extensive-thromboses-in-a-patient-with-subdural-hematoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.99999","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}